Large-volume apheresis for the harvest of peripheral blood progenitor cells for autologous transplantation

Transfusion

Volumn 37, Issue 2, 1997, Pages 188-192

  Smolowicz, A G ^a   Villman, K ^a   Tidefelt, U ^a  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR;

APHERESIS; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD COMPONENT THERAPY; BLOOD DYSCRASIA; BLOOD VOLUME; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; PERIPHERAL BLOOD STEM CELL; SOLID TUMOR;

EID: 0031041814     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37297203522.x     Document Type: Article

References (18)

1. + cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 1996;17:509-15.
2. Haas R, Möhle R, Fruhauf S, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994;83:3787-94.
3. + PBSC transplantation: optimizing factors for hematologic recovery (abstract). Bone Marrow Transplant 1995;15(Suppl 2):S35.
4. Martinez C, Mateu R, Sureda A, et al. Collection of PBSC mobilized by salvage chemotherapy (IAPVP-16) plus G-CSF and autografting for resistant lymphomas (abstract). Bone Marrow Transplant 1995;15(Suppl 2):S36.
5. Dreger P, Klöss M, Petersen B, et al. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 1995;86:3970-8.
6. Remes K, Itälä M, Kampilla M, et al. Analysis of failures in mobilisation of PBSC (abstract). Bone Marrow Transplant 1995;15(Suppl 2):S35.
7. Tarella C, Caracciolo D, Gavarotti P, et al. Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization. Bone Marrow Transplant 1995;16:223-8.
8. Olivieri A, Offidani M, Ciniero L, et al. Optimization of the yield of PBSC for autotransplantation mobilized by high-dose chemotherapy and G-CSF: proposal for a mathematical model. Bone Marrow Transplant 1994;14:273-8.
9. Carella AM, Podesta M, Frassoni F, et al. Collection of "normal" blood repopulating cells during early hematopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Transplant 1993;12:267-71.
10. Carella AM, Chimirri F, Podestà M, et al. High-dose chemoradiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. Bone Marrow Transplant 1996;17:201-5.
11. Carella AM, Frassoni F, Pollicardo N, et al. Philadelphia-chromosome-negative peripheral blood stem cells can be mobilized in the early phase of recovery after a myelosuppressive chemotherapy in Philadelphia-chromosome-positive acute lymphoblastic leukaemia. Br J Haematol 1995;89:535-8.
12. Podestà M, Piaggio G, Frassoni F, et al. Very primitive hemopoietic cells (LTC-IC) are present in Philadelphia negative cytaphereses collected during early recovery after chemotherapy for chronic myeloid leukemia (CML). Bone Marrow Transplant 1995;16:549-55.
13. Comenzo RL, Vosburgh LE, Weintraub LR, et al. Collection of mobilized blood progenitor cells for hematopoietic rescue by large-volume leukapheresis. Transfusion 1995;35:493-7.
14. + cell analysis: technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. Nordic Myeloma Study Group Laboratories. J Hematother 1995;4:21-8.
15. Siena S, Bregni M, Di Nicola M, et al. Milan protocol for clinical CD34+ cell estimation in peripheral blood for autografting in patients with cancer. In: Wunder E, Sovalat H, Hénon PR, Serke S, eds. Hematopoietic stem cells. The Mulhouse manual. Dayton: AlphaMed Press, 1994:23-30.
16. Hillyer CD, Tiegerman KO, Berkman EM. Increase in circulating colony-forming units-granulocyte-macrophage during large-volume leukapheresis: evaluation of a new cell separator. Transfusion 1991;31:327-32.
17. Haas R, Möhle R, Pförsich M, et al. Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells. Blood 1995;85:1936-43.
18. - cells reselected from macrophage inflammatory protein 1α+interleukin-3 - supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells. Blood 1994;84:1442-9.